68Ga-Psma PET/CT Response and Clinical Outcomes in Patients Treated with Enzalutamide As First-Line Therapy for Metastatic Castration-Resistant Prostate Cancer (mcrpc): Results of a Prospective Study.
Journal of Clinical Oncology(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要